Post sponsored by NewzEngine.com

Source: Pharmac

What we’re doing

We are pleased to announce the approval of non-exclusive listing agreements with LifeHealthcare Limited (“LifeHealthcare”) and Surgical Innovations Limited (“Surgical Innovations”) for the supply of orthopaedic implants and associated products (“Orthopaedic Products”).

In summary, this will result in LifeHealthcare and Surgical Innovations ranges of Orthopaedic Products being listed in Part III of Section H of the Pharmaceutical Schedule from 1 April 2020.

DHBs will be able to continue to purchase other suppliers’ brands of Orthopaedic Products as the agreements are not for sole supply.

Detail about this decision

In April 2016 PHARMAC issued a request for proposals (“RFP”) for orthopaedic implants and associated products. The RFP requested proposals for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

After evaluating LifeHealthcare’s and Surgical Innovation’s proposals and consulting on the provisional agreements reached with them, PHARMAC has decided to list LifeHealthcare’s and Surgical Innovation’s ranges of Orthopaedic Products in Part III of Section H of the Pharmaceutical Schedule from 1 April 2020.

These two agreements are the final agreements that will be entered into in the orthopaedic products category as a result of the RFP. 

The following product ranges and brands are included in the agreements:

Supplier

Product ranges

Brands

LifeHealthcare

CMF

Neurosurgical implants 

Level 1

Spinal Implants

Anterior Spine Truss,Cervical Spine Truss, Posterior Spine Truss

Aleutian Rages

Anchor ranges

Ari

Aviator

AVS ranges

Blue Ridge

Capri

CarboClear

Cascadia

Cayman

Chesapeake

Denali

EIT Smart Spinal

ES2

Everest

Fixation Nav

I-Factor

Mantis

Mesa

Natural Bridge

Nile

Oasys

OIC

Pyrenees

Reflix HYB

Santorini

Serengeti

Solis ranges

Tasman

UNILIF

VBOSS

VLIFT

XIA ranges

Yukon 

Surgical Innovations

Distal joint and Trauma implants

Active Fuse

Activmotion

Alians ranges

Eclipse

Footmotion

Initial ranges

New Clip 

Spinal Implants

ADD/ADDPlus

Ecipse

Obelisc

Surgical bone cements and Allografts

Allograft

Copal

Genex

Maxxeus DBM

Osteomycin ranges

Palabowl

Palacos

Palamix

Stimulan

Pulse Lavage

Clean

Our response to what you told us

We appreciate the time people took to respond to this consultation.

All consultation responses received by 13 February 2020 and 25 February 2020, respectively, were considered in their entirety in making the decision to approve each agreement.

A summary of the main themes raised in feedback and our responses to the feedback are set out below: 

Theme Comment
LifeHealthcare and Surgical Innovations  
No technical or resource impacts are exected as a result of the proposals Noted
Surgical Innovations  
Savings opportunity noted Noted

If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.

Last updated: 3 March 2020

MIL OSI